Proliferative Diabetic Retinopathy Market Size
Market Size in USD Bn
CAGR11.8%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 11.8% |
| Market Concentration | Medium |
| Major Players | Novartis, Roche, Bayer, Regeneron Pharmaceuticals, Allergan and Among Others |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Proliferative Diabetic Retinopathy Market Analysis
The Proliferative Diabetic Retinopathy Market is estimated to be valued at USD 2.70 Bn in 2025 and is expected to reach USD 5.89 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032. The market is primarily driven by the rising cases of diabetes across the globe. Strong product pipeline and increasing availability of various treatment options are proving conducive for market growth.